In vitro sensitization of the B16 murine melanoma cells to ganciclovir by different RNA and plasmid DNA constructions encoding HSVtk

Gene Therapy

Volumn 3, Issue 10, 1996, Pages 913-918

  Yarovoi, S V ^a,b   Mouawad, R ^a   Colbere Garapin F ^c   Soubrane, C ^a   Khayat, D ^a   Rixe, O ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SIDNEY KIMMEL CANCER CENTER   (United States)

^c INSTITUT PASTEUR   (France)

Author keywords

HSVtk gene; HSVtk gene transcripts; Plasmids; Transfection of melanoma cells

Indexed keywords

GANCICLOVIR; PLASMID DNA; RNA; THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; DRUG CYTOTOXICITY; DRUG SENSITIZATION; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIVIRAL AGENTS; CELL SURVIVAL; DNA, VIRAL; DRUG CARRIERS; GANCICLOVIR; GENE DOSAGE; HUMANS; LIPOSOMES; MELANOMA, EXPERIMENTAL; MICE; PLASMIDS; RNA, VIRAL; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; HERPES; MAMMALIA; MURINAE; SIMPLEXVIRUS;

EID: 0029912779     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Moolten FL. Drug sensitivity ('suicide') genes for selective cancer chemotherapy. Cancer Gene Ther 1994; 1: 279-287.
2. Bi WL, Parysek LM, Warnick R, Stambrook PJ. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSVtk retroviral gene therapy. Hum Gen Ther 1993; 4: 725-731.
3. Freeman SM et al. The 'bystander effect': tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274-5283.
4. Vile RG et al. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res 1994; 54: 6228-6234.
5. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy Cancer Res 1986; 46: 5276-5271.
6. Huber BE, Richards CA, Krenitsky TA. Retroviral mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy Proc Natl Acad Sci USA 1991, 88: 8039-8043.
7. Anderson WF. Human gene therapy. Science 1992; 256: 808-813.
8. Culver KW et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain rumors. Science 1992; 256: 1550-1552.
9. Mullen CA, Kilstrup M, Blaese RM Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA 1992; 89. 33-37.
10. Miller AD. Human gene therapy comes of age. Nature 1992; 357. 455-460.
11. Austin EA, Huber BE. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of E coli cytosine deaminase Mol Pharmacol 1993; 43: 380-387.
12. Mulligan RC, Berg P. Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribo-syltransferase. Proc Natl Acad Sci USA 1981; 78: 2072-2076.
13. Besnard C, Monthioux E, Jami J. Selection against expression of the Escherichia coli gene gpt in hprt mouse teratocarcinoma and hybrid cells. Mol Cell Biol 1987; 7: 4139-4141.
14. Mroz PJ, Moolten FL. Retrovirally transduced Escherichia coli gpt genes combine selectability with chemosensitivity capable of mediating tumor eradication. Hum Gene Ther 1993; 4: 589-595.
15. Sorscher EJ et al. Tumor cell bystander killing in colonic carcinoma utilising the Escherichia coli DeoD gene to generate toxic purines. Gene Therapy 1994; 1: 233-238.
16. Vile RG, Russel SJ. Gene transfer technologies for the gene therapy of cancer. Gene Therapy 1994; 1: 88-98.
17. Wu GY, Wilson JM, Shalaby F. Receptor-mediated gene delivery in vivo. Partial correction of genetic analbunemia in Nagase rats. J Biol Chem 1991; 266: 14338-14342.
18. Hug P, Sleight RG. Liposomes for the transformation of eukaryotic cells. Biochem Biophys Acta 1991; 1097: 1-17.
19. Davis HL et al. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum Gene Ther 1993; 4: 733-740.
20. Vile RG, Hart IR. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res 1993; 53: 3860-3864.
21. Nabel GJ et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 1993; 90: 11307-11311.
22. Calvez V et al. Virus-free transfer of the herpes simplex virus thymidine kinase gene followed by ganciclovir treatment induces tumor cell death. Clin Cancer Res 1996; 2: 47-51.
23. Soubrane CI et al. Direct gene transfer of a plasmid carrying HSV-TK gene in transplanted murine melanoma: in vivo study. Eur J Cancer 1996; 32A: 691-695.
24. Madaio MP, Hodder S, Schwartz RS, Stollar BD. Responsiveness of autoimmune and normal mice to nucleic acid antigens. J Immunol 1984; 132: 872-876.
25. Smythe WR et al. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res 1994; 54. 2055-2059.
26. Chen S-H et al. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 1994; 91: 3054-3057.
27. Schewach DS et al. Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells. Cancer Gene Ther 1994; 1: 107-112.
28. Stewart MJ et al. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum Gene Ther 1992; 3: 267-275.
29. Nabel GJ et al. Immunotherapy for cancer by direct gene transfer in tumors. Hum Gene Ther 1994; 5: 57-77.
30. Malone RW, Feigner PL, Verma IM. Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci USA 1989; 86: 6077-6081.
31. Malone RW. mRNA transfection of cultured eukaryotic cells and embryos using cationic liposomes. Life Technologies 1989; 11: 61-65.
32. Lu D et al. Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors. Cancer Gene Ther 1994; 1: 245-252.
33. Green PJ, Pines O, Inouye M. The role of antisense RNA in gene regulation. Annu Rev Biochem 1986; 55: 569-597.
34. Izant JG, Weintraub H. Inhibition of thymidine kinase gene expression by anti-sense RNA: a molecular approach to genetic analysis. Cell 1984; 36: 1007-1015.
35. Matthews T, Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis 1988; 10: 490-494.
36. Field AK et al. 9-{[2-hydroxy-1 (hydroxymethyl)ethoxy]methyl} guanine: a selective inhibitor of herpes group virus replication. Proc Natl Acad Sci USA 1983; 80: 4139-4143.
37. Colbère-Garapin F et al. Cloning of the active thymidine kinase gene of herpes simplex virus type 1 in Escherichia coli K-12. Proc Natl Acad Sci USA 1979; 76: 3755-3759.
38. Birnboim HC, Doly J. A rapid alkaline extraction procedure for screening of recombinant plasmid DNA. Nucleic Acids Res 1979; 7: 1513-1523.
39. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1982, pp 202-203.